Diagnostic evaluation of a mildly ataxic young gelding Quarterhorse included a contrast myelogram. Unfortunately, sodium diatrizoate was inappropriately administered by intrathecal injection resulting in severe unrelenting seizure activity and necessitated the destruction of the animal. The contrast agent was identified by analyzing cerebrospinal fluid by high-performance liquid chromatography and confirmed with probe mass spectrometric analysis. This contrast agent is highly ionic, has high osmolarity, and also blocks neurotransmission at specific receptors; for these reasons it is contraindicated for use in myelography. This is the first report of intrathecal administration of this agent in a horse, although there has been a previous report of similar untoward reactions in a dog, and numerous cases have been reported in humans.
A 2-year 3-month-old Quarterhorse gelding was presented to a veterinarian with the complaint of mild ataxia, consisting primarily of mild occasional stumbling when being ridden, according to the owner. Further neurologic examination results were not provided. The diagnostic plan was to place the horse under general anesthesia, then perform a cerebrospinal fluid (CSF) tap to obtain CSF for an equine protozoal myelitis Western blot assay, and finally perform a contrast myelogram to evaluate the cervical cord for extradural compressions indicative of possible cervical stenotic myelopathy (wobbler syndrome). The horse was anesthetized, intubated, and placed on an inhalant anesthetic machine. The dorsal aspect of the proximal cervical area was shaved and disinfected, and approximately 50 ml of CSF was extracted by needle and syringe from the subarachnoid space at the atlantooccipital space without incident. Next, approximately 50 ml of unidentified contrast agent was injected into the subarachnoid space through the same needle, and several radiographs were taken. However, when the plane of anesthesia was being reduced by decreasing the rate of flow of inhalant anesthetic agent, the horse immediately developed violent seizures that included thrashing of the head, neck, and all 4 limbs. The seizures were controlled only by intravenous administration of diazepam and increasing the flow of inhalant anesthetic agent. During the next 6-8 hours, any time the plane of anesthesia was decreased the seizures started again. Subsequently the horse was humanely eutha- nized by intravenous administration of short-acting barbiturate because its condition did not improve.
The gelding was submitted to the Diagnostic Center for Population and Animal Health, Michigan State University, East Lansing, MI, for necropsy the next morning. The history was provided as above, however, the specific product and concentration used to perform the contrast myelography was not identified. Furthermore, the owner of the animal was not satisfied with the diagnostic procedure that resulted in the destruction of this horse, and there were specific legal implications involved in the necropsy examination. The skin over the dorsal neck had been shaved, and a single needle puncture was present along the midline over the atlantooccipital joint. The skin around the eye on the left side of the face had multiple abrasions and lacerations. The 2 lateralmost upper incisors on the left side of the maxilla had been broken off, and the adjacent gums were hemorrhagic. Before removing the head at the atlantooccipital joint as per our routine necropsy protocol, the ventral midline skin and musculature were dissected, and the trachea was removed, exposing the underlying cervical spinal column. A needle was inserted from the ventral aspect of the vertebral column along the midline into the cerebellomedullary cistern at the atlantooccipital junction, which provides a convenient 2-3-cm-diameter unobstructed exposure to the ventral aspect of the spinal cord when the head is slightly hyperextended. Approximately 5 ml of CSF, without any gross contamination by blood, was removed for toxicologic analysis. After removal of the CSF, the head was removed and a full necropsy examination was performed. The most significant finding was a complete transverse fracture of the vertebral body of C3, which likely occurred during the violent thrashing of the head and neck during this animal's seizure activity the previous night. In ad-dition, there appeared to be some gross narrowing/ compression of the spinal cord at the levels of cervical vertebrae C4, C5, and C6. However, histologic examination of the cervical spinal cord for typical demyelination of the white matter was equivocal. Histologic evaluation of the brain revealed the presence of shrunken, angular, and hypereosinophilic neurons with pyknotic nuclei. Whether these degenerate neurons were the result of hypoxia, direct toxicity of the contrast agent, or early postmortem change is unknown. The cause of this horse's ataxia was presumed to be cervical stenotic myelopathy; however, there was neither radiographic nor histologic confirmation of this diagnosis. Furthermore, the owner's principal concern at necropsy was to determine the cause of the animal's seizures, not the ataxia.
Cerebrospinal fluid and reference sodium diatrizoate a were analyzed by high-performance liquid chromatography (HPLC) using paired-ion chromatography on a reversed-phase system. b The mobile phase consisted of 90% 0.005 M PIC-A (tetrabutylammonium phosphate) b /10% acetonitrile run at a flow rate of 0.9 ml/minute on a 4.6 ϫ 150-mm, 10-m Bondapak C18 column, b with UV detection at 258 nm. b The retention time for reference diatrizoate was 8.39 minutes, and for the major peak in the CSF the retention time was 8.11 minutes. The concentration of diatrizoate in the CSF was 4,800 ppm by HPLC. The presence of diatrizoate in the CSF was confirmed by comparison of the reference diatrizoate and CSF fragmentation patterns obtained by positive-ion electron ionization mass spectrometry. Because of the ionic nature of the diatrizoate, a direct insertion probe c was used to introduce the reference diatrizoate and CSF into the ion source of the mass spectrometer. The high concentration of diatrizoate in the CSF made possible the mass spectral identification from untreated CSF.
The diagnostic work-up on this case was challenging for several reasons. First, because of the intrathecal administration of the contrast dye agent it was critical that CSF be harvested for the toxicologic analysis. Because of the highly ionic nature of the contrast agent used, it is doubtful that sufficient contrast agent would have been present in either the brain or other tissues commonly harvested for toxicologic analysis (liver, kidney, adipose tissue) that it would have been successfully identified from those samples. Fortunately, based on the case history, the CSF was collected early in the necropsy protocol. Once having obtained the CSF sample and having tentatively identified the injected contrast agent as diatrizoate by HPLC, we wished to confirm the identity by mass spectrometry. Sodium diatrizoate, a salt, is far too polar to chromatograph on gas chromatography-mass spectrometr, so we tried analysis by direct insertion probe mass spectrometry. Fortunately, the extremely high concentration of the compound in the CSF allowed unequivlocal confirmation with reference material by this method.
When the product insert for sodium diatrizoate a is consulted, it clearly states that the product is designed for intravenous, not intrathecal administration, and that intrathecal administration can result in side effects including seizures. Unfortunately, this warning was not heeded in the current case. A review of the veterinary literature revealed a single case report of inadvertent intrathecal administration in a Pekingese dog. 5 In that case, after the contrast myelography and surgical hemilaminectomy procedures were completed, the dog developed seizure activity, which required pentobarbital-induced anesthesia for an additional 36 hours to control. However, the animal did recover completely.
Interestingly, although there is limited information on intrathecal administration of sodium diatrizoate in the veterinary literature, there is much more extensive information available from the human literature. In one review of inadvertent administration of iodinated water-soluble contrast media-including diatrizoate-for myelography, 3 of 7 human subjects died of resulting neurotoxicity. 4 Another report describes a human subject who received an overdose of intravenous diatrizoate, who subsequently developed prolonged seizures and transient parkinsonism signs due to spillover of the agent into the central nervous system. 3 In fact, diatrizoate has been incriminated as the most frequent cause of adverse neurologic signs in humans receiving inadvertent intrathecal injections of contrast agents. 2 Sodium diatrizoate is a water-soluble, hyperosmolar, contrast agent that contains 3 iodine atoms in its molecular structure. Water-soluble, hyperosmolar contrast agents have been demonstrated to produce severe disruption of the blood-brain barrier when administered intrathecally. 1, 5 In addition, the iodine atoms in diatrizoate have been shown to be directly neurotoxic on rat hypothalamus sections. 5 More recently, studies have demonstrated that diatrizoate competitively binds with human dopamine-2 receptors, resulting in the blockage of neurotransmissions through those receptors. 2 This may result in immediate parkinsonism-like effects. Therefore, diatrizoate potentially results in neurotoxicity through several different mechanisms.
This case summarizes the clinical course, necropsy findings, and toxicologic investigation of an inappropriately administered iodine-containing, water-soluble contrast agent. It emphasizes that extreme caution should be observed when injecting materials by the intrathecal route as well as the dire consequences that may result if inappropriate materials are used. Cerebrospinal fluid should be routinely collected at necropsy in all cases where unexplained seizures or other neurologic signs are manifest because this may prove to be the critical sample needed for toxicologic or other diagnostic testing modalities. Ideally, CSF would be collected at the time of the animal's euthanasia and submitted with the animal to the diagnostic laboratory for further analysis.
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